Impact of Infant Formula on Caregiver-perceived Intolerance



Status:Recruiting
Conditions:Healthy Studies
Therapuetic Areas:Other
Healthy:No
Age Range:Any
Updated:12/9/2018
Start Date:September 24, 2018
End Date:February 1, 2019
Contact:Laura Czerkies
Email:laura.czerkies@us.nestle.com
Phone:815-630-5223

Use our guide to learn which trials are right for you!

Understand the impact of switching to a commercially available infant formula on
gastrointestinal symptoms


Inclusion Criteria:

- Healthy infant

- Full-term (> 37 weeks gestation)

- Birth weight > 2500 and < 4500 g

- 14-60 days of age on enrollment

- Singleton birth

- Infant's mother has elected not to breastfeed prior to enrollment

- Infant exclusively formula-fed for at least 5 days prior to enrollment

- Caregiver perceives infant as very or extremely fussy according to perceived fussiness
based on the previous 3 days

- Caregiver wishes to switch infant's formula

- Has not received solid foods

- Having obtained his/her legal representative's informed consent

Exclusion Criteria:

- Known or suspected cow-milk allergy

- Currently receiving a specialty infant formula (e.g. thickened, extensively
hydrolyzed, amino acid-based, metabolic)

- Has switched formula more than two times since hospital discharge

- Currently experiencing gastrointestinal or respiratory symptoms secondary to an
ongoing infection or virus (e.g. gastrointestinal infection, upper respiratory
infection, flu)

- Congenital illness or malformation that may affect infant feeding and/or growth

- Any readmission to hospital (except for hyperbilirubinemia) prior to enrollment

- Receiving probiotic supplements

- Infant's family who in the Investigator's assessment cannot be expected to comply with
treatment (feeding regimen).

- Participation in another study that has not been approved as a concomitant study by
Nestlé Nutrition.
We found this trial at
7
sites
Waxahachie, Texas 75165
Principal Investigator: Peggy Linguist, MD
?
mi
from
Waxahachie, TX
Click here to add this to my saved trials
2051 Charlie Hall Boulevard
Charleston, South Carolina 29414
Principal Investigator: Kelli Johnston, MD
Phone: 843-518-5642
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Dayton, Ohio 45414
Principal Investigator: Julie Shepard, MD
Phone: 937-424-9294
?
mi
from
Dayton, OH
Click here to add this to my saved trials
Layton, Utah 84041
Principal Investigator: Adam Hutchinson, MD
Phone: 801-773-4840
?
mi
from
Layton, UT
Click here to add this to my saved trials
1707 Bender Road
Memphis, Tennessee 38116
Principal Investigator: James Carter, MD
Phone: 901-396-8436
?
mi
from
Memphis, TN
Click here to add this to my saved trials
Norwich, Connecticut 06360
Principal Investigator: Richard Geller, MD
?
mi
from
Norwich, CT
Click here to add this to my saved trials
Owensboro, Kentucky 43201
Principal Investigator: Carroll Howard, MD
?
mi
from
Owensboro, KY
Click here to add this to my saved trials